SHERWOOD, OR--(Marketwired - Jul 14, 2014) - Entia Biosciences Inc. (OTCQB: ERGO), an emerging leader in the field of nutrigenomics, has been awarded a grant by The Michael J. Fox Foundation for ...

SHERWOOD, OR / ACCESSWIRE / September 30, 2014 / Entia Biosciences, Inc. (ERGO), an emerging leader in the field of nutrigenomics, today announced the publication of a study demonstrating the ...

Careology and Entia have announced a partnership to enhance cancer care through innovative digital and at-home solutions. The collaboration aims to empower patients to self-manage aspects of their ...

LONDON, UK 26 July 2023 – Healthtech company Entia has closed a successful £16m Series A financing round. The round was led by BGF and Parkwalk plus other existing investors, with the capital ...

Through Entia’s virtual oncology platform, patients are able to perform their own blood tests Pfizer UK has announced a new partnership with virtual oncology company Entia in a bid to fast-track the ...

LONDON; 13 th May 2024: Entia’s new, home-use, full blood count analyser that provides personalised and preventative care for cancer patients outside of hospital has been approved for use in the UK.

Add Yahoo as a preferred source to see more of our stories on Google. A British healthcare company which allows patients to perform blood tests at home to aid their cancer treatment has received a ...

Entia Biosciences Inc. Annual stock financials by MarketWatch. View the latest ERGO financial statements, income statements and financial ratios.

@2024 - All Right Reserved.

A high-level overview of Entia Biosciences, Inc. (ERGO) stock. View (ERGO) real-time stock price, chart, news, analysis, analyst reviews and more.